An in vitro study to elucidate the effects of Septilin TM on immune pathways

Authors

  • Mujeeb Hoosen (Coordinator of Unani-Tibb), School of Natural Medicine, Faculty of Community and Health Sciences, The University of the Western Cape, Bellville
  • Edmund John Pool (Professor of Microbiology), The Department of Medical Biosciences, Faculty of Natural Sciences, The University of the Western Cape, Bellville

DOI:

https://doi.org/10.3329/bjms.v17i2.35877

Keywords:

SeptilinTM, immune pathways biomarkers, immunomodulatory, herbal medicinal products, whole blood cultures

Abstract

Objective: The use of herbal immunomodulatory preparations to prevent and treat immunological complications is increasing in popularity. Rigorous in vitro, in vivo and clinical trial studies are needed to ensure safety, quality and efficacy for the wellbeing of patients. SeptilinTM, a proprietary herbal medicinal product has been reported to have immunomodulatory effects. This study investigated the in vitro effects of SeptilinTM on biomarkers of specific immune pathways by using whole blood culture assays (WBC).

Materials and Methods: Stimulated and unstimulated WBC have been incubated with the product. Enzyme linked immunosorbent assays have been used to screen for IL-6, IL-10, and IFN γ as biomarkers for inflammation, humoral immunity, and cell mediated immunity, respectively.

Results: SeptilinTM had no effect on the release of IL-6 production by (lipopolysaccharide) LPS stimulated WBC across all concentrations tested. However, SeptilinTM induced significant higher levels (P<0.001) of IL-6 release in unstimulated WBC across all concentrations between 0µg/ml-258µg/ml. SeptilinTM had no effect on the release of IL-10 release in unstimulated WBC across all concentrations. However the presence of SeptilinTM in phytohaemagglutinin (PHA) stimulated WBC induced significant higher release (P<0.01) of IL-10 release at concentrations between 64.5µg/ml- 258µg/ml when compared to the control. The presence of SeptilinTM in unstimulated WBC had no effect on the release of IFN γ production across all concentrations. The presence of SeptilinTM in PHA stimulated WBC release of IFN γ is inconclusive.

Conclusion: This study shows that SeptilinTM has immunomodulatory effects on WBC in vitro.

Bangladesh Journal of Medical Science Vol.17(2) 2018 p.238-244

Downloads

Download data is not yet available.
Abstract
1220
PDF
899

Author Biography

Mujeeb Hoosen, (Coordinator of Unani-Tibb), School of Natural Medicine, Faculty of Community and Health Sciences, The University of the Western Cape, Bellville



Downloads

Published

2018-03-23

How to Cite

Hoosen, M., & Pool, E. J. (2018). An in vitro study to elucidate the effects of Septilin TM on immune pathways. Bangladesh Journal of Medical Science, 17(2), 238–244. https://doi.org/10.3329/bjms.v17i2.35877

Issue

Vol. 17 No. 2 (2018)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.